Oxygenated N-aryl-diazacyclic compounds

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544295, 544336, 544405, 544408, 544337, 544332, 544331, 544329, 544328, 544319, 544316, 544296, 544238, 424258, 424251, 424267, 546194, 546201, 546210, 546141, 546143, 546162, 546153, 546265, 546273, 546278, A61K 31495, C07D40114

Patent

active

042173507

ABSTRACT:
A process known per se for the manufacture of oxygenated N-aryl-diazacyclic compounds of the formula ##STR1## wherein each of R.sub.1 and R.sub.2 represents a substituted or unsubstituted aryl group and alk represents a lower alkylene group which separates both nitrogen atoms from each other by 2 or 3 carbon atoms, or salts thereof.
The novel compounds can be used as antihypertensives, antitachycardiac agents and .alpha.-receptor blockers.

REFERENCES:
patent: 4144344 (1979-03-01), Eichenberger et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Oxygenated N-aryl-diazacyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxygenated N-aryl-diazacyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxygenated N-aryl-diazacyclic compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2182529

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.